Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine

García-Rodríguez, 2002, Dynamics of nasopharyngeal colonization by potential respiratory pathogens., J Antimicrob Chemother, 50, 59, 10.1093/jac/dkf506

Tzanakaki, 2007, Etiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean region., Int J Antimicrob Agents, 29, 621, 10.1016/j.ijantimicag.2006.11.031

Butler, 1996, The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Sentinel Surveillance System., J Infect Dis, 174, 986, 10.1093/infdis/174.5.986

Kaltoft, 2000, Epidemiology of invasive pneumococcal infections in children aged 0–6 years in Denmark: a 19-year nationwide surveillance study., Acta Paediatr Suppl, 89, 3, 10.1111/j.1651-2227.2000.tb00775.x

Mulholland, 1999, Strategies for the control of pneumococcal diseases., Vaccine, 17, S79, 10.1016/S0264-410X(99)00112-7

Levine, 2006, Pneumococcal vaccination in developing countries., Lancet, 367, 1880, 10.1016/S0140-6736(06)68703-5

Kilpi, 2001, Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life., Pediatr Infect Dis J, 20, 654, 10.1097/00006454-200107000-00004

Eskola, 2001, Efficacy of a pneumococcal conjugate vaccine against acute otitis media., N Engl J Med, 344, 403, 10.1056/NEJM200102083440602

Rosenblut, 2001, Bacterial and viral etiology of acute otitis media in Chilean children., Pediatr Infect Dis J, 20, 501, 10.1097/00006454-200105000-00006

Arguedas, 2003, Microbiology of otitis media in Costa Rican children, 1999 through 2001., Pediatr Infect Dis J, 22, 1063, 10.1097/01.inf.0000101189.81501.e9

Leibovitz, 2003, Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae., Pediatr Infect Dis J, 22, 509, 10.1097/01.inf.0000069759.79176.e1

Leibovitz, 2004, Haemophilus influenzae: A Significant pathogen in acute otitis media., Pediatr Infect Dis J, 23, 1142, 10.1097/01.inf.0000148233.57296.90

Arguedas, 2005, Middle ear fluid Streptococcus pneumoniae serotype distribution in Costa Rican children with otitis media., Pediatr Infect Dis J, 24, 631, 10.1097/01.inf.0000168748.92510.45

O'Brien, 2004, Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases., Am J Epidemiol, 159, 634, 10.1093/aje/kwh082

Black, 2000, Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children., Pediatr Infect Dis J, 19, 187, 10.1097/00006454-200003000-00003

Akkoyunlu, 1991, Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains., Infect Immun, 59, 1231, 10.1128/IAI.59.4.1231-1238.1991

Janson, 1993, Limited diversity of the protein D gene (hpd) among encapsulated and nonencapsulated Haemophilus influenzae strains., Infect Immun, 61, 4546, 10.1128/IAI.61.11.4546-4552.1993

Munson, 1993, Protein D, a putative immunoglobulin D-binding protein produced by Haemophilus influenzae, is glycerophosphodiester phosphodiesterase., J Bacteriol, 175, 4569, 10.1128/JB.175.14.4569-4571.1993

Song, 1995, The gene encoding protein D (hpd) is highly conserved among Haemophilus influenzae type b and nontypeable strains., Infect Immun, 63, 696, 10.1128/IAI.63.2.696-699.1995

Janson, 1994, Protein D, the glycerophosphodiester phosphodiesterase from Haemophilus influenzae with affinity for human immunoglobulin D, influences virulence in a rat otitis model., Infect Immun, 62, 4848, 10.1128/IAI.62.11.4848-4854.1994

Janson, 1999, Effects on the ciliated epithelium of protein D-producing and -nonproducing nontypeable Haemophilus influenzae in nasopharyngeal tissue cultures., J Infect Dis, 180, 737, 10.1086/314921

Prymula, 2006, Pneumococcal capsular polysaccharides conjugated to protein D provide protection against otitis media caused by both Streptococcus pneumoniae and nontypable Haemophilus influenzae: a randomized double blind efficacy study., Lancet, 367, 740, 10.1016/S0140-6736(06)68304-9

Jódar, 2003, Serological criteria for evaluations and licensure of new pneumococcal conjugate vaccine formulations for use in infants., Vaccine, 21, 3265, 10.1016/S0264-410X(03)00230-5

Lee, 2003, Correlates of immunity for pneumococcal conjugate vaccines., Vaccine, 21, 2190, 10.1016/S0264-410X(03)00025-2

Siber, 2007, Estimating the protective concentration of anti-pneumococcalcapsular polysaccharide antibodies., Vaccine, 25, 3816, 10.1016/j.vaccine.2007.01.119

Concepcion, 2001, Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay., Clin Diagn Lab Immunol, 8, 266, 10.1128/CDLI.8.2.266-272.2001

Henckaerts, 2006, Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with or without 22F inhibition at low antibody concentrations in pediatric sera., Clin Vaccine Immunol, 13, 356, 10.1128/CVI.13.3.356-360.2006

Quataert, 1995, Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S., Clin Diagn Lab Immunol, 2, 590, 10.1128/CDLI.2.5.590-597.1995

Romero-Steiner, 2003, Multi-laboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae., Clin Diagn Lab Immunol, 10, 1019, 10.1128/CDLI.10.6.1019-1024.2003

Henckaerts, 2007, Validation of a routine pneumococcal opsonophagocytosis assays to predict invasive pneumococcal disease efficacy of conjugate vaccine in children., Vaccine, 25, 2518, 10.1016/j.vaccine.2006.09.029

Carpenter, 2000, Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians., Statist Med, 19, 1141, 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F

O'Brien, 2003, Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial., Lancet, 362, 355, 10.1016/S0140-6736(03)14022-6

Klugman, 2003, A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection., N Engl J Med, 349, 1341, 10.1056/NEJMoa035060

Tuomanen, 1995, Pathogenesis of pneumococcal infection., New Engl J Med, 332, 1280, 10.1056/NEJM199505113321907

Poolman, 2004, Pneumococcal vaccine development., Expert Rev Vaccines, 3, 597, 10.1586/14760584.3.5.597

Schuerman, 2006, ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media., Vaccine, 25, 1953, 10.1016/j.vaccine.2006.12.007

Schuerman, 2006, Kinetics of the immune response following pneumococcal PD conjugate vaccination., Vaccine, 25, 1962, 10.1016/j.vaccine.2006.12.008

Ekström, 2005, Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial., Infect Immun, 73, 369, 10.1128/IAI.73.1.369-377.2005

Ruggeberg, 2007, Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants., Vaccine, 25, 264, 10.1016/j.vaccine.2006.07.036

Moore, 2008, Population snapshot of emergent Streptococcus pneumoniae Serotype 19A in the United States, 2005., J Infect Dis, 197, 1016, 10.1086/528996

Choi, 2008, Streptococcus pneumoniae Serotype 19A in children, South Korea., Emerg Infect Dis, 14, 275, 10.3201/eid1402.070807